UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Protalix BioTherapeutics, Inc.

Florida		001-33357		65-0643773
(State or other jurisdiction		(Commission File Number)		(IRS Employer
of incorporation)				Identification No.)

2 Snunit Street
Science Park, POB 455
Carmiel, Israel		20100
(Address of principal executive offices)		(Zip Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders

The Annual Meeting of Shareholders of Protalix BioTherapeutics, Inc. (the “Company”) was held on November 7, 2010. At the meeting:

(1)

eight persons were elected to serve as directors of the Company; and

(2)

the shareholders ratified the appointment of Kesselman & Kesselman, Certified Public Accountant (Isr.), A member of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2010.

Set forth below, with respect to each such matter, are the number of votes cast for, number of votes cast against or withheld, as applicable, the number of abstentions and the number of broker non-votes.

(1)

Election of Directors

										Broker
		For				Withheld				Nonvotes
Zeev Bronfeld			37,820,831				3,087,283				6,679,555
David Aviezer, Ph.D., MBA			40,862,741				45,373				6,679,555
Yoseph Shaaltiel, Ph.D.			40,862,741				45,373				6,679,555
Alfred Akirov			40,847,941				60,173				6,679,555
Amos Bar Shalev			40,851,441				56,673				6,679,555
Yodfat Harel Gross			40,851,441				56,673				6,679,555
Roger D. Kornberg, Ph.D.			40,859,741				48,373				6,679,555
Eyal Sheratzky			40,830,841				77,273				6,679,555

(2)

Approval of Kesselman & Kesselman

For		Against		Abstain		Broker Nonvotes
47,511,896		68,378		7,395		—

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.